Bioquark, a US biotech company was granted ethical permission to recruit 20 patients who were declared clinically dead from a traumatic brain injury, and test if their central nervous system can be brought back to life.
These biotech scientists will be using various therapies, this includes injecting the patient’s brain with stem cells and a mixture of peptides, and nerve-stimulating techniques. The trial participants will have been certified dead and kept alive through life support. They will be monitored closely for several months using brain imaging equipment to check for signs of regeneration. The scientist believes that the brain stem cells may be able to erase history and start life all over again.
“This represents the first trial of its kind and another step towards the eventual reversal of death in our lifetime,” Dr. Ira Pastor, the CEO of Bioquark said. “We just received approval for our first 20 subjects and we hope to start recruiting patients immediately from this first site – we are working with the hospital now to identify families where there may be a religious or medical barrier to organ donation.
“To undertake such a complex initiative, we are combining biologic regenerative medicine tools with other existing medical devices typically used for stimulation of the central nervous system, in patients with other severe disorders of consciousness.”
“We hope to see results within the first two to three months.
